The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis

Journal of Clinical Pathology

Volumn 57, Issue 10, 2004, Pages 1009-1014

  Greijer, A E ^a   Van Der Wall, E ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCL 2 ADENOVIRUS E1B 19 KDA INTERACTING PROTEIN 3; HYPOXIA INDUCIBLE FACTOR 1; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN; PROTEIN BAX; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; DISEASE SEVERITY; HUMAN; HYPOXIA; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN INDUCTION; PROTEIN STABILITY; REVIEW; SOLID TUMOR; STRESS; TUMOR RESISTANCE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL HYPOXIA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INHIBITOR OF APOPTOSIS PROTEINS; MEMBRANE PROTEINS; NECROSIS; NEOPLASMS; NUCLEAR PROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION FACTORS;

EID: 4944246547     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.015032     Document Type: Review

References (84)

1. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-32.
2. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
3. Rice GC, Hoy C, Schimke RT. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci U S A 1986;83:5978-82.
4. Young SD, Marshall RS, Hill RP. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A 1988;85:9533-7.
5. Coquelle A, Toledo F, Stern S, et al. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell 1998;2:259-65.
6. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996;56:5754-7.
7. Saikumar P, Dong Z, Patel Y, et al. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 1998;17:3401-15.
8. Aragones J, Jones DR, Martin S, et al. Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor-1 by low oxygen tension. J Biol Chem 2001;276:10548-55.
9. Santore MT, McClintock DS, Lee VY, et al. Anoxia-induced apoptosis occurs through a mitochondria-dependent pathway in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L727-34.
10. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.
11. Hickman JA, Patten CS, Merritt AJ, et al. Apoptosis and cancer chemotherapy. Philos Trans R Soc Lond B Biol Sci 1994;345:319-25.
12. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1 alpha or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394:485-90.
13. Moritz W, Meier F, Stroka DM, et al. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1 alpha expression. FASEB J 2002;16:745-7.
14. Akakura N, Kobayashi M, Horiuchi I, et al. Constitutive expression of hypoxia-inducible factor-1 alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 2001;61:6548-54.
15. Kotch LE, Iyer NV, Laughner E, et al. Defective vascularization of HIF-1 alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 1999;209:254-67.
16. Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O-2 homeastasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998;12:149-62.
17. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998;17:3005-15.
18. Zhong H, Agani F, Baccala AA, et al. Increased expression of hypoxia inducible factor-1 alpha in rat and human prostate cancer. Cancer Res 1998;58:5280-4.
19. Jiang BH, Agani F, Passaniti A, et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 1997;57:5328-35.
20. Halterman MW, Miller CC, Federoff HJ. Hypoxia-inducible factor-1 alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci 1999;19:6818-24.
21. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor-1. J Biol Chem 1995;270:1230-7.
22. Salceda S, Beck I, Caro J. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch Biochem Biophys 1996;334:389-94.
23. Semenza GL. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002;64:993-8.
24. Krieg M, Haas R, Brauch H, et al. Up-regulation of hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 2000;19:5435-43.
25. Epslein ACP, Gleadle JM, McNeill LA, et al. C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001;107:43-54.
26. Jaokkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O-2-regulated prolyl hydroxylation. Science 2001;292:468-72.
27. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001;294:1337-40.
28. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 alpha. Genes Dev 2000;14:34-44.
29. Bae MK, Ahn MY, Jeong JW, et al. Jab1 interacts directly with HIF-1 alpha and regulates its stability. J Biol Chem 2002;277:9-12.
30. Miller DL, Dibbens JA, Damert A, et al. The vascular endothelial growth factor mRNA contains an internal ribosome entry site. FEBS Lett 1998;434:417-20.
31. Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1 alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell 2002;13:1792-801.
32. Kvietikova I, Wenger RH, Marti HH, et al. The transcription factors Atf-1 and Creb-1 bind constitutively to the hypoxia-inducible factor-1 (Hif-1) DNA recognition site. Nucleic Acids Res 1995;23:4542-50.
33. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002;64:993-8.
34. Schepop HAM, de Jong JS, van Diest PJ, et al. Counting of apoptotic cells: a methodological study in invasive breast cancer. Mol Pathol 1996;49:M214-17.
35. McClintock DS, Santore MT, Lee VY, et al. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 2002;22:94-104.
36. Gross A, Yin XM, Wang K, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999;274:1156-63.
37. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-30.
38. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-89.
39. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997;22:299-306.
40. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
41. Fulda S, Meyer E, Debatin KM. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000;60:3947-56.
42. Morishima N, Nakanishi K, Takenouchi H, et al. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 2002;277:34287-94.
43. Kim JY, Park JH. ROS-dependent caspase-9 activation in hypoxic cell death. FEBS Lett 2003;549:94-8.
44. Basu S, Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene 1998;17:3277-85.
45. Kunz M, Ibrahim S, Koczan D, et al. Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma. Cell Growth Differ 2001;12:137-45.
46. Dong Z, Wang JZ, Yu F, et al. Apoptosis-resistance of hypoxic cells: multiple factors involved and a role for IAP-2. Am J Pathol 2003;163:663-71.
47. Dong Z, Nishiyama J, Yi XL, et al. Gene promoter of apoptosis inhibitory protein IAP2: identification of enhancer elements and activation by severe hypoxia. Biochem J 2002;364:413-21.
48. Holcik M, Lefebvre C, Yeh CL, et al. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol 1999;1:190-2.
49. Devarajan P, De Leon M, Talasazan F, et al. The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways. J Biol Chem 2001;276:40599-605.
50. Alvarez-Tejado M, Naranjo-Suarez S, Jimenez C, et al. Hypoxia induces the activation of the phosphatidyinositol 3-kinase/Akt cell survival pathway in PC12 protective role in apoptosis. J Biol Chem 2001;276:22368-74.
51. Bacus SS, Altomare DA, Lyass L, et al. AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival. Oncogene 2002;21:3532-40.
52. Brusselmans K, Bono F, Maxwell P, et al. Hypoxia-inducible factor-2 alpha (HIF-2 alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia. J Biol Chem 2001;276:39192-6.
53. Chen D, Li M, Luo J, et al. Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 2003;278:13595-8.
54. Hansson LO, Friedler A, Freund S, et al. Two sequence motifs from HIF-1 alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci U S A, 2002;99:10305-9.
55. An WG, Kanekal M, Simon MC, et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1 alpha. Nature 1998;392:405-8.
56. Sowter HM, Ratcliffe PJ, Watson P, et al. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001;61:6669-73.
57. Boyd JM. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994;79:1121.
58. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A, 2000;97:9082-7.
59. Kothari S, Cizeau J, McMillan-Ward E, et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003;22:4734-44.
60. Vande Velde C, Cizeau J, Dubik D, et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000;20:5454-68.
61. Chen J, Zhao SJ, Nakada K, et al. Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol 2003;162:1283-91.
62. Piret JP, Mottet D, Raes M, et al. Is HIF-1 alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 2002;64:889-92.
63. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91.
64. Tsang RW, Fyles AW, Milosevic M, et al. Interrelationship of proliferation and hypoxia in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;46:95-9.
65. Kennedy AS, Raleigh JA, Perez GM, et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys 1997;37:897-905.
66. Webster L, Hodgkiss RJ, Wilson GD. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours. Cytometry 1995;21:344-51.
67. Raleigh JA, Zeman EM, Calkins DP, et al. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. Acta Oncol 1995;34:345-9.
68. Nordsmark M, Hoyer M, Keller J, et al. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1996;35:701-8.
69. Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003;67:3-15.
70. Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995;37:1-9.
71. Tsang RW, Wong CS, Fyles AW, et al. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome. Radiother Oncol 1999;50:93-101.
72. Sheridan MT, Cooper RA, West CM. A high ratio of apoptosis to proliferation correlates with improved survival after radiotherapy or cervical adenocarcinoma. Int J Radiat Oncol Biol Phys 1999;44:507-12.
73. Wheeler JA, Stephens LC, Tornos C, et al. ASTRO research fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 1995;32:1487-93.
74. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res 1999;59:5830-5.
75. Bos R, Zhong H, Hanrahan CF, et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 2001;93:309-14.
76. Bos R, Van Der Groep, Greijer AE, et al. Levels of hypoxia-inducible factor-1 alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003;97:1573-81.
77. Costa A, Coradini D, Carrassi A, et al. Re: Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 2001;93:1175-7.
78. Bos R, Van Diest PJ, Van Der Wall E. Response: levels of hypoxia-inducible factor-1a during breast carcinogenesis. J Natl Cancer Inst 2001;93:1177.
79. Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000;20:1527-33.
80. Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000;20:1527-33.
81. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 2001;85:881-90.
82. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, et al. Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer. Int J Cancer 1997;74:565-70.
83. Unruh A, Ressel A, Mohamed HG, et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 2003;22:3213-20.
84. Aebrsold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor-1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001;61:2911-16.